Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A radical explanation for glucose-induced β cell dysfunction
Michael Brownlee
Michael Brownlee
Published December 15, 2003
Citation Information: J Clin Invest. 2003;112(12):1788-1790. https://doi.org/10.1172/JCI20501.
View: Text | PDF
Commentary Article has an altmetric score of 2

A radical explanation for glucose-induced β cell dysfunction

  • Text
  • PDF
Abstract

The development of type 2 diabetes requires impaired β cell function. Hyperglycemia itself causes further decreases in glucose-stimulated insulin secretion. A new study demonstrates that hyperglycemia-induced mitochondrial superoxide production activates uncoupling protein 2, which decreases the ATP/ADP ratio and thus reduces the insulin-secretory response. These data suggest that pharmacologic inhibition of mitochondrial superoxide overproduction in β cells exposed to hyperglycemia could prevent a positive feed-forward loop of glucotoxicity that drives impaired glucose tolerance toward frank type 2 diabete

Authors

Michael Brownlee

×

Total citations by year

Year: 2024 2023 2022 2020 2019 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Total
Citations: 1 2 1 1 2 3 1 3 5 4 3 4 6 2 2 2 2 44
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2010 (4)

Title and authors Publication Year
Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger
M Novelli, B Bonamassa, M Masini, N Funel, D Canistro, VD Tata, M Martano, A Soleti, D Campani, M Paolini, P Masiello
Naunyn-Schmiedeberg's Archives of Pharmacology 2010
Autoregulation of Free Radicals via Uncoupling Protein Control in Pancreatic β-Cell Mitochondria
WJ Heuett, V Periwal
Biophysical Journal 2010
The Clinical Application of Ozonetherapy
Bocci V
2010
Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation
F Folli, V Guzzi, L Perego, DK Coletta, G Finzi, C Placidi, SL Rosa, C Capella, C Socci, D Lauro, D Tripathy, C Jenkinson, R Paroni, E Orsenigo, G Cighetti, L Gregorini, C Staudacher, A Secchi, A Bachi, M Brownlee, P Fiorina
PloS one 2010

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 3 X users
52 readers on Mendeley
See more details